Wilson 2020.
Study characteristics | ||
Study design | Mathematical modelling study
|
|
Disease | COVID‐19 | |
Travel‐related control measure(s) | Screening at national borders and quarantine of travellers
Date of implementation: n.r. |
|
Country implementing the measure(s) | Country protected by the measure: New Zealand (hypothetical disease free area) Country restricted by the measure: Australia (hypothetical low prevalence area) |
|
Outcome(s) | Shift in epidemic development
|
|
Notes | COI: “The authors have no competing interests.” Funding: “Professor Wilson is supported by the New Zealand Health Research Council (16/443) and Ministry of Business Innovation and Employment (MBIE) funding of the BODE3 Programme (UOOX1406). Professor Michael Baker is supported by a New Zealand Health Research Council grant for research on COVID‐19 (20/1066).” |